GeneXpert System
Cepheid's GeneXpert system family combines speed, accuracy, and simplicity to deliver PCR results anywhere testing is needed. The system automates sample preparation, PCR amplification, and detection using self-contained GeneXpert test cartridges.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
I would recommend this product
Strep test
This machine is fast accurate and works great in clinic setting.
Review Date: 26 Jan 2026 | Cepheid
I am a laboratory technician that uses this instrument often and in different settings. We run many strep tests.
Molecular Strep A Detection Laboratory Clinic
I feel this instrument has rarely had any complications or issues, and is fast and efficient. Compared to other instruments in my lab, I would consider this our most reliable. The maintenance is simple and isn’t required frequently. The few times I have had any questions, finding where to call and experiencing the customer service was excellent.
Review Date: 26 Jan 2026 | Cepheid
Gene Xpert is a Game changer with instant results for quality patient management
The equipment is really a medical game changer. We have seen how the tests that could take us weeks be performed instant
Gene Xpert is saving many lives in remote areas with instant results. What used to take us weeks to receive results is now miraculously done within 24 hours not disrupting or inconveniencing a client. I recommend each Clinic to have this equipment if attainable
Review Date: 26 Nov 2025 | Cepheid
I would recommend the Cepheid GeneXpert for its ease of use and dependability.
PCR testing in lab
The Cepheid GeneXpert is one of my favorite analyzers in the microbiology lab. It is dependable and very user friendly. I rarely have any issues with it that simple trouble shooting can not resolve. The customer service team is usually very knowledgeable as well. We run the 4plex covid/flu/rsv, MRSA, and C.diff testing on our Cepheid. Turn around times are great and testing setup is simple and easy.
Review Date: 18 Nov 2025 | Cepheid
Very user-friendly analyzer available
Rapid nucleic acid amplification test for detection of microorganisms and antibiotic sensitivity
Easy to use, walk away, and in 30-90 minutes, depending on the test, you have results. Reliable results with high reproducibility, if you follow the user instructions (no bubbles or particles in the cartridge). Low maintenance, and easy to scale up. The price of cartridges is justified by the other benefits for the lab.
Review Date: 4 Mar 2024 | Cepheid
Great instrument. Worth it for my lab
Detection of Tb in sputum samples
Very reliable instrument. Easy to operate and maintain.
Review Date: 26 May 2023 | Cepheid
Accurate and reliable results
Molecular Diagnostic
Faster turn around time, easy training and clear manufactures information. Easy to maintain and cost effective. Does not occupy much space. Tolerant to temperature changes.
Review Date: 3 Feb 2023 | Cepheid
Fast results, easy to use, Maintenace done yearly after sale, highly recommended
rapid TBPCR test
easy to use, fast results
Review Date: 23 Nov 2022 | Cepheid
Wonderful product. I just love it!
Detection of Tuberculosis as well as Rifampicin resistance in sputum and stool samples
The product has fair sensitivity and specificity for diagnosing smear-negative pulmonary TB. It is faster than culture and can detect rifampicin-resistant strains of MTB. Very user-friendly. We receive awesome after-sales care from the retailer and training provider. It is worth it! With its effectiveness and non-time-consuming technique, we are getting the value for our money.
Review Date: 1 Apr 2022 | Cepheid
Excellent equipment - easy to use with good results.
Respiratory virus testing
Product is highly effective, extremely easy to implement, validate and operate. Early in the pandemic, test kits were a bit difficult to obtain due to supply issues. However, by Summer of 2020, products have been readily available. Test kits/results are high quality (accuracy an precision) however, quite costly.
Review Date: 4 Feb 2022 | Cepheid
The GeneXpert System is a closed, self-contained, fully-integrated and automated platform that represents a paradigm shift in the automation of molecular analysis, producing accurate results in a timely manner with minimal risk of contamination.
The GeneXpert System is the only system to combine on-board sample preparation with real-time PCR (polymerase chain reaction) amplification and detection functions for fully integrated and automated nucleic acid analysis. The system is designed to purify, concentrate, detect and identify targeted nucleic acid sequences thereby delivering answers directly from unprocessed samples.
Modular in design, the GeneXpert System has a variety of configurations to meet the broad range of testing demands of any clinical environment.
From emerging threats to diagnostic breakthroughs: A strategic look ahead in AMR
Wednesday, May 27 at 16:00 BST | 17:00 CEST | 11:00 EDT | 08:00 PDT
Don’t miss this chance to learn from industry professionals in a dynamic session filmed at ESCMID Global 2026 followed by a live Q&A session. Brought to you by Danaher companies, Beckman Coulter Diagnostics and Cepheid, this session will explore the role of emerging diagnostic modalities to combat the development and spread of antimicrobial resistance (AMR).
The session will apply lessons learned from MRSA and VRE testing to emerging AMR threats such as CRE and C. auris. There will be an exploration of AMR gene detection using molecular methods such as syndromic PCR panels and NGS. Besides molecular methods, we will explore emerging rapid phenotypic antimicrobial susceptibility tests (AST) and bacterial versus viral host response-based diagnostics and their potential to improve antimicrobial stewardship and patient outcomes.
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Webinar details
- Cost: Free to attend
- Location: Online
- Duration: 90 minutes
- Format: Rebroadcast of recorded symposium from ESCMID Global 2026 with live Q&A
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.
Improving acute infection diagnosis using host- and pathogen-focused approaches – A rebroadcast from SAEM26 with live Q&A
Tuesday, June 16 at 16:00 BST | 17:00 CEST | 11:00 EDT | 8:00 PDT
This SelectScience® webinar features a rebroadcast from the Society for Academic Emergency Medicine 2026 Annual Meeting (SAEM26), followed by a live Q&A session.
Diagnostic uncertainty in acute infections remains a core challenge in emergency medicine. Brought to you by Danaher companies, Beckman Coulter Diagnostics and Cepheid, this webinar examines two complementary diagnostic strategies to help close this gap: pathogen-based testing and host response biomarkers.
The first session will review evidence-based approaches to pharyngitis including clinical scoring systems and diagnostic strategies for Group A Strep detection such as PCR. The second session introduces new host-response tests to differentiate bacterial from viral infection.
Through case-driven discussions, participants will explore practical workflows, stewardship alignment, and clinical impact including time-to-diagnosis, antibiotic optimization, clinical outcomes, and patient disposition.
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Webinar details
- Cost: Free to attend
- Location: Online
- Duration: 60 minutes
- Format: Rebroadcast of recorded symposium from SAEM26 with live Q&A
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.
Managing antimicrobial resistance: A healthcare system's approach to antimicrobial detection and stewardship
Over the past five years, healthcare systems have faced a troubling rise in Gram-negative multidrug-resistant organisms (MDROs), contributing to increased patient morbidity and mortality. At the forefront of this surge are NDM-CREs (New Delhi metallo-β-lactamase-producing carbapenem-resistant Enterobacterales), which have skyrocketed by 460% between 2019 and 2023, according to a recent report from the Centers for Disease Control and Prevention (CDC)1. Another report by the European Centre for Disease Control (ECDC) showed a 57% increase in bloodstream infections caused by carbapenem resistant bacteria in the same time period2.
These alarming trends underscore the urgent need for robust screening protocols and precise antibiotic susceptibility testing, especially for high-risk patient populations.
Join our group of industry experts for an insightful case-based webinar exploring the complex patient journey of a 76-year-old woman residing in a nursing home. Her story begins with a fall leading to an emergency room visit where she is found to have a hip fracture. She is admitted and has an uneventful surgical repair the next day but develops urosepsis during her post-op recovery.
This case highlights the heightened vulnerability of elderly patients to MDROs, particularly CREs. Through this patient’s journey, the speakers will examine the critical role of infection prevention protocols and the value of accurate diagnostic and antibiotic susceptibility testing in guiding effective treatment as they are applied throughout a healthcare system.
The session will also incorporate the latest IDSA guidelines for managing complicated urinary tract infections, including urosepsis, offering practical insights for clinicians, microbiologists, and infection control professionals.
Key learning objectives:
- Describe how rapid PCR screening plays a critical role in enhancing infection control protocols to help minimize transmission and support timely patient management.
- Explain how rapid AST results support optimal antimicrobial therapy decision-making to help improve patient outcomes and combat resistance.
- Outline the latest IDSA guidelines for complicated urinary tract infections.
- Discuss the impact of antimicrobial resistance and diagnostic stewardship in real-world settings.
Who should attend?
Clinical microbiology lab directors/supervisors/managers, microbiologists, microbiologist lab technicians, infectious disease specialists, infectious disease pharmacists, clinical microbiology lab executives, antibiotic stewardship committee members, infection preventionists
Accreditation statement
SelectScience® is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.
References:
1. CDC Report Finds Sharp Rise in Dangerous Drug-Resistant Bacteria | CDC Newsroom
2. Antimicrobial resistance in the EU/EEA (EARS-Net) - Annual Epidemiological Report 2023
Bringing rapid genomic sequencing into routine infection management
Infectious diseases are evolving rapidly, driven by emerging pathogens and rising antimicrobial resistance. In this video, clinical and industry leaders from Oxford Nanopore Technologies, Cepheid, and King’s College London explore how rapid genomic sequencing could transform the detection, management, and prevention of infections in the future.
As part of their expanded collaboration, Cepheid and Oxford Nanopore have worked together to develop a new research workflow that combines automated sample and library preparation with innovative nanopore-based sequencing. Experts representing the developers and one of the early research users of this integrated approach discuss how innovations such as lab‑in‑a‑cartridge technology and minimal hands‑on processes could support broader adoption and benefits beyond specialist laboratories.
For Research Use Only. Not for use in diagnostic procedures.
Interview recorded at ESCMID Global 2026.
New rapid molecular test for tuberculosis can detect resistance in less than 90 minutes
Used to empower clinicians to quickly prescribe treatment regimens for multidrug-resistant TB, the test could help fill a critical gap that is jeopardizing global TB targets
Cepheid announces development of combination test for four viral infections
These four viral infections have similar patient presentations, making accurate detection and differentiation critical during next flu season
Cepheid receives FDA emergency use authorization for SARS-CoV-2 test
The Xpert Xpress SARS-CoV-2 test is designed for the qualitative detection of the virus causing COVID-19
